Search
for
Sort by
Research 181–210 of 1000+
- Penatalaksanaan Alopecia Areata (Treatment of Allopecia Areata)
- Diphencyprone in the treatment of Satoyoshi syndrome
- Efficient In Vivo Targeting of Epidermal Stem Cells by Early Gestational Intraamniotic Injection of Lentiviral Vector Driven by the Keratin 5 Promoter
- Azelaic Acid in Dermatology: A Review of Its Mechanism of Action
- Hair Loss in Women
- Evidence of Heterogeneity and Quantitative Differences of the Type 1 5α-Reductase Expression in Cultured Human Skin Cells – Evidence of its Presence in Melanocytes
- A Critical Review on Obstetric Follow-up of Women Affected by Systemic Lupus Erythematosus
- Evolution, classification, structure, and functional diversification of steroid 5α-reductase family in eukaryotes
- Immunosuppressive therapy in autoimmune disease — A review
- Alopecia Areata in an Adolescent With Inflammatory Bowel Disease
- Post-natal development of rats` offspring treated with the ethanol extract of Neem leaves (<i>Azadirachta indica</i> A. Juss) during pregnancy and lactation
- Role of 5α-reductase inhibitors in androgen-stimulated skin disorders.
- Case report: NUDT15 polymorphism and severe azathioprine-induced myelosuppression in a young Chinese female with systematic lupus erythematosus: a case analysis and literature review
- Formulation and Evaluation of Herbal Face Pack
- Herbal Formulation for Hair Growth Promotion and Scalp Health
- Formulation and evaluation of hair fall control herbal hair oil
- Alopecia Areata: Current Review
- A Filipino with Systemic Lupus Erythematosus-Scleroderma Overlap Syndrome
- Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics
- Oral Finasteride (5 mg and 2 mg) versus Topical Minoxidil 5% in Female Pattern Hair Loss
- 4‐MAPC, a 5α‐Reductase Inhibitor, Reduces Rat Ventral Prostate Weight, DNA, and Prostatein Concentrations
- Synthesis and Actions of 5α-Reduced Metabolites of Testosterone in the Nervous System
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- Actions of 5α-reductase inhibitors on the epididymis
- Null Mutation of 5α-Reductase Type I Gene Alters Ethanol Consumption Patterns in a Sex-Dependent Manner
- 17-Oximino-5-androsten-3β-yl esters: synthesis, antiproliferative activity, acute toxicity, and effect on serum androgen level
- Comparison of efficacy and safety of tofacitinib and azathioprine in patients with alopecia areata and variants: a double-blind, randomized controlled trial
- A Convenient Synthesis of (16S,20S)-3β-Hydroxy-5α-pregnane-20,16-carbolactam and Its N-alkyl Derivatives
- Efficacy and Safety of 5% Minoxidil Alone, Minoxidil Plus Oral Spironolactone, and Minoxidil Plus Microneedling on Female Pattern Hair Loss: A Prospective, Single-Center, Parallel-Group, Evaluator Blinded, Randomized Trial
- Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor